Collection
MeSH Terms
Neuroendocrine Carcinoma, Gastroenteropancreatic neuroendocrine tumor, Phase 3 Clinical Trial, Phase 4 Clinical Trial, Randomized Controlled Trial, Guideline, Systematic Review, Quality Assessment, Adult, Octreotide, 177Lu-Dotatate, 90y-Dotatate
Keywords
Guideline, Midgut Neuroendocrine Tumours, Pancreatic Neuroendocrine Tumours, Systemic Therapy, Systematic Review
Date for Review
The Program in Evidence-based Care (PEBC), Ontario Health (CCO) has an annual review process for each guideline. Guidelines are reviewed every fall, one year after they are completed
Publication Date
March 2024
Date of Last Evidence Search
October 30, 2023
Methods Applied
Evidence-based; Systematic review-based; External review; Evidence quality assessment; Patient/survivor/caregiver participation
Guideline Contact
Roxanne Cosby; [email protected]
Publication Scope
treatment
Countries of Application
Canada
Guideline Publication Status
Published
Languages
English
Authors
PEBC (Program in evidenced-based care)
Publication Year
2024